Codexis's major customers
Codexis appears in 8 disclosed customer relationships between 2012 and 2019.
Get an email when Codexis's customer concentration changes
When a new annual report adds a 10% customer, drops one, or moves a share by 5 points or more, you get the change and the filing link. Up to 10 companies per address, no account, unsubscribe with one click.
Major customers of Codexis
Customers that Codexis named in its annual report as 10% or more of revenue. A missing year means the customer was below that line or not named.
Formerly disclosed
| Customer | Share of revenue | Change vs prior year | History | Latest filing |
|---|---|---|---|---|
| ShellSHEL | 51% | last FY 2012 | 1 year | FY 2012 · filed 6 Mar 2015 |
| Merck & Co.MRK | 29% | last FY 2018 | 7 years | FY 2018 · filed 1 Mar 2019 |
| GSKGSK | 22% | last FY 2016 | 3 years | FY 2016 · filed 1 Mar 2019 |
| Nestle | 22% | last FY 2018 | 2 years | FY 2018 · filed 1 Mar 2019 |
| Exela | 21% | last FY 2014 | 2 years | FY 2014 · filed 6 Mar 2015 |
| NovartisNVS | 14% | last FY 2017 | 3 years | FY 2017 · filed 1 Mar 2019 |
| Tate Lyle | 13% | last FY 2018 | 2 years | FY 2018 · filed 1 Mar 2019 |
| Exela Pharm Sci | 12% | last FY 2015 | 1 year | FY 2015 · filed 15 Mar 2018 |
About this data
US-listed companies must disclose revenue from any single customer that reaches 10% of their total (ASC 280). ShadowGraph reads these disclosures from the XBRL data of every 10-K and 20-F we scan, keeps one value per fiscal year (restatements replace earlier values) and links each number to its filing. Companies that describe a customer only as "Customer A" are not listed by name. Figures are as reported; nothing here is investment advice.
All companies · Latest dependency shifts · Bulk data and API